CHMP details positive opinions from February meeting
This article was originally published in Scrip
Executive Summary
Europe's Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions on CSL Behring's Hizentra, Provepharm's methylthioninium chloride Proveblue, generic ibandronic acid from both Sandoz and Hexal,while extending the label for Abbott's Humira.